Takeda Pharmaceutical TAK
NYSE TAK
$20.25 -0.12 (-0.59%)
At close: Oct 23, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Sale and Maturity of Investments (2018 - 2026)

Updated

Analysis

Takeda Pharmaceutical (TAK) Sale and Maturity of Investments (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Takeda Pharmaceutical 64.44 Bn 40.82 Bn 5.10 Bn 2.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.35 Mn
Mar 31, 2026 14.93 Mn
Dec 31, 2025 10.14 Mn
Sep 30, 2025 19.56 Mn
Jun 30, 2025 7.80 Mn
Mar 31, 2025 396.26 Mn
Dec 31, 2024 23.44 Mn
Sep 30, 2024 119.32 Mn
Jun 30, 2024 34.16 Mn
Mar 31, 2024 46.78 Mn
Dec 31, 2023 3.10 Mn
Sep 30, 2023 609,349.41
Jun 30, 2023 3.96 Mn
Mar 31, 2023 12.86 Mn
Dec 31, 2022 15.24 Mn
Sep 30, 2022 88.49 Mn
Jun 30, 2022 47.77 Mn
Mar 31, 2022 7.37 Mn
Jun 30, 2021 4.41 Mn
Mar 31, 2021 8.38 Mn
API Access

Takeda Pharmaceutical Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=TAK&period=max&api_key=YOUR_API_KEY